These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24423625)

  • 1. Inhibition of insulin receptor function by a human, allosteric monoclonal antibody: a potential new approach for the treatment of hyperinsulinemic hypoglycemia.
    Corbin JA; Bhaskar V; Goldfine ID; Issafras H; Bedinger DH; Lau A; Michelson K; Gross LM; Maddux BA; Kuan HF; Tran C; Lao L; Handa M; Watson SR; Narasimha AJ; Zhu S; Levy R; Webster L; Wijesuriya SD; Liu N; Wu X; Chemla-Vogel D; Lee SR; Wong S; Wilcock D; Rubin P; White ML
    MAbs; 2014; 6(1):262-72. PubMed ID: 24423625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved glucose metabolism in vitro and in vivo by an allosteric monoclonal antibody that increases insulin receptor binding affinity.
    Corbin JA; Bhaskar V; Goldfine ID; Bedinger DH; Lau A; Michelson K; Gross LM; Maddux BA; Kuan HF; Tran C; Lao L; Handa M; Watson SR; Narasimha AJ; Zhu S; Levy R; Webster L; Wijesuriya SD; Liu N; Wu X; Chemla-Vogel D; Lee SR; Wong S; Wilcock D; White ML
    PLoS One; 2014; 9(2):e88684. PubMed ID: 24533136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective allosteric antibodies to the insulin receptor for the treatment of hyperglycemic and hypoglycemic disorders.
    Issafras H; Bedinger DH; Corbin JA; Goldfine ID; Bhaskar V; White ML; Rubin P; Scannon PJ
    J Diabetes Sci Technol; 2014 Jul; 8(4):865-73. PubMed ID: 24876415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unique allosteric insulin receptor monoclonal antibody that prevents hypoglycemia in the SUR-1
    Patel P; Charles L; Corbin J; Goldfine ID; Johnson K; Rubin P; De León DD
    MAbs; 2018 Jul; 10(5):796-802. PubMed ID: 29589989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control.
    Bhaskar V; Goldfine ID; Bedinger DH; Lau A; Kuan HF; Gross LM; Handa M; Maddux BA; Watson SR; Zhu S; Narasimha AJ; Levy R; Webster L; Wijesuriya SD; Liu N; Wu X; Chemla-Vogel D; Tran C; Lee SR; Wong S; Wilcock D; White ML; Corbin JA
    Diabetes; 2012 May; 61(5):1263-71. PubMed ID: 22403294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of anti-insulin receptor antibodies as potential novel therapies for human insulin receptoropathy using cell culture models.
    Brierley GV; Siddle K; Semple RK
    Diabetologia; 2018 Jul; 61(7):1662-1675. PubMed ID: 29700562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Insulin Receptor Antibodies Improve Hyperglycemia in a Mouse Model of Human Insulin Receptoropathy.
    Brierley GV; Webber H; Rasijeff E; Grocott S; Siddle K; Semple RK
    Diabetes; 2020 Nov; 69(11):2481-2489. PubMed ID: 32816962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous Insulin Receptor
    Sethi A; Foulds N; Ehtisham S; Ahmed SH; Houghton J; Colclough K; Didi M; Flanagan SE; Senniappan S
    J Clin Res Pediatr Endocrinol; 2020 Nov; 12(4):420-426. PubMed ID: 31989990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique pharmacology of a novel allosteric agonist/sensitizer insulin receptor monoclonal antibody.
    Hinke SA; Cieniewicz AM; Kirchner T; D'Aquino K; Nanjunda R; Aligo J; Perkinson R; Cooper P; Boayke K; Chiu ML; Jarantow S; Lacy ER; Liang Y; Johnson DL; Whaley JM; Lingham RB; Kihm AJ
    Mol Metab; 2018 Apr; 10():87-99. PubMed ID: 29453154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of Insulin Action by an Allosteric Insulin Receptor Antibody in Healthy Volunteers.
    Johnson KW; Neale A; Gordon A; Roessig J; Bezwada P; Vukelich S; Goldfine I; Rubin P
    J Clin Endocrinol Metab; 2017 Aug; 102(8):3021-3028. PubMed ID: 28605468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XMetA, an allosteric monoclonal antibody to the insulin receptor, improves glycaemic control in mice with diet-induced obesity.
    Bhaskar V; Lau A; Goldfine ID; Narasimha AJ; Gross LM; Wong S; Cheung B; White ML; Corbin JA
    Diabetes Obes Metab; 2013 Mar; 15(3):272-5. PubMed ID: 23039274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cells.
    Chan JY; LaPara K; Yee D
    Oncogene; 2016 Aug; 35(32):4235-43. PubMed ID: 26876199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual Glycemic Presentations in a Child with a Novel Heterozygous Intragenic INSR Deletion.
    Verdecchia F; Akcan N; Dastamani A; Morgan K; Semple RK; Shah P
    Horm Res Paediatr; 2020; 93(6):396-401. PubMed ID: 33040071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hyperinsulinemia induced miR-27b is linked to adipocyte insulin resistance by targeting insulin receptor.
    Srivastava A; Shankar K; Beg M; Rajan S; Gupta A; Varshney S; Kumar D; Gupta S; Mishra RK; Gaikwad AN
    J Mol Med (Berl); 2018 Apr; 96(3-4):315-331. PubMed ID: 29455245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Insulin Receptor in Breast Cancer Using Small Engineered Protein Scaffolds.
    Chan JY; Hackel BJ; Yee D
    Mol Cancer Ther; 2017 Jul; 16(7):1324-1334. PubMed ID: 28468775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-insulin receptor autoantibodies in a patient with type B insulin resistance and fasting hypoglycemia.
    Yamasaki H; Yamaguchi Y; Fujita N; Kato C; Kuwahara H; Yamauchi MD; Yamakawa K; Abe T; Ozaki M; Sera Y; Uotani S; Kawasaki E; Takino H; Eguchi K
    Acta Diabetol; 2000; 37(4):189-96. PubMed ID: 11450502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent hypoglycemia during pregnancies in a woman with multiple autoantibodies including anti-insulin receptor antibody and anti-platelet antibody, whose serum lowered murine blood glucose levels and phosphorylated insulin receptor of CHO-IR cells.
    Toshihiro M; Katagiri H; Kataoka K; Fukushima A; Segawa T; Fujiwara T; Hikichi I; Takebe N; Satoh J
    Endocr J; 2011; 58(12):1037-43. PubMed ID: 21931226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hyperinsulinemia on hepatic insulin receptor concentration and autophosphorylation in the presence of high growth hormone levels in transgenic mice overexpressing growth hormone gene.
    Dominici FP; Balbis A; Bartke A; Turyn D
    J Endocrinol; 1998 Oct; 159(1):15-25. PubMed ID: 9795337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe insulin resistance in disguise: A familial case of reactive hypoglycemia associated with a novel heterozygous INSR mutation.
    Innaurato S; Brierley GV; Grasso V; Massimi A; Gaudino R; Sileno S; Bernardini S; Semple R; Barbetti F
    Pediatr Diabetes; 2018 Jun; 19(4):670-674. PubMed ID: 29411486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel In Vitro Assay Correlates Insulin Receptor Autoantibodies With Fasting Insulin in Type B Insulin Resistance.
    Minich WB; Abel BS; Schwiebert C; Welsink T; Seemann P; Brown RJ; Schomburg L
    J Clin Endocrinol Metab; 2023 Aug; 108(9):2324-2329. PubMed ID: 36869714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.